Common Stock, Shares, Outstanding of Akari Therapeutics Plc from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Akari Therapeutics Plc quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2011 to 30 Sep 2025.
  • Akari Therapeutics Plc Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 65,229,461,523, a 169% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Akari Therapeutics Plc Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 65,229,461,523 +40,940,230,000 +169% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 65,229,461,523 +65,206,336,635 +281975% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 57,752,981,523 +41,779,860,225 +262% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 53,186,919,523 +39,952,604,225 +302% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 24,289,231,523 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 23,124,888 -10,099,196,635 -100% 30 Jun 2024 8-K 06 Sep 2024
Q1 2024 15,973,121,298 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 13,234,315,298 +13,214,532,551 +66798% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q2 2023 10,122,321,523 +4,187,404,400 +71% 30 Jun 2023 6-K 29 Sep 2023 2023 Q2
Q4 2022 19,782,747 -4,739,949,176 -100% 31 Dec 2022 8-K 06 Sep 2024
Q2 2022 5,934,917,123 +2,087,585,200 +54% 30 Jun 2022 6-K 27 Sep 2022 2022 Q2
Q4 2021 4,759,731,923 +912,400,000 +24% 31 Dec 2021 20-F 01 May 2023 2022 FY
Q2 2021 3,847,331,923 +460,758,810 +14% 30 Jun 2021 6-K 22 Sep 2021 2021 Q2
Q4 2020 3,847,331,923 +1,601,466,010 +71% 31 Dec 2020 20-F 16 May 2022 2021 FY
Q2 2020 3,386,573,113 +1,735,879,700 +105% 30 Jun 2020 6-K 01 Sep 2020 2020 Q2
Q4 2019 2,245,865,913 +2,245,553,894 31 Dec 2019 20-F 21 Apr 2021 2020 FY
Q2 2019 1,650,693,413 +125,000,020 +8.2% 30 Jun 2019 6-K 29 Aug 2019 2019 Q2
Q4 2018 312,019* -1,525,381,374 31 Dec 2018 20-F 21 Apr 2021 2020 FY
Q2 2018 1,525,693,393 +348,000,000 +30% 30 Jun 2018 6-K 27 Sep 2018 2018 Q2
Q4 2017 1,525,693,393 +348,000,010 +30% 31 Dec 2017 20-F 23 Apr 2019 2018 FY
Q2 2017 1,177,693,393 +10 0% 30 Jun 2017 6-K 10 Aug 2017 2017 Q2
Q4 2016 1,177,693,383 0 0% 31 Dec 2016 20-F 18 Jul 2018 2017 FY
Q2 2016 1,177,693,383 +1,122,057,100 +2017% 30 Jun 2016 6-K 14 Apr 2017 2016 Q2
Q1 2016 1,177,693,383 +1,122,057,100 +2017% 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q4 2015 1,177,693,383 +455,347,783 +63% 31 Dec 2015 6-K 14 Apr 2017 2016 Q2
Q3 2015 1,177,693,383 30 Sep 2015 10-Q 23 Nov 2015 2015 Q3
Q2 2015 55,636,283 30 Jun 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 55,636,283 31 Mar 2015 10-Q 12 May 2015 2015 Q1
Q4 2014 722,345,600 +682,117,647 +1696% 31 Dec 2014 10-K 23 Mar 2016 2015 FY
Q4 2013 40,227,953 +26,858,144 +201% 31 Dec 2013 10-K 11 Feb 2015 2014 FY
Q4 2012 13,369,809 +1,271,212 +11% 31 Dec 2012 20-F 24 Mar 2014 2013 FY
Q4 2011 12,098,597 31 Dec 2011 20-F/A 19 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.